To determine if there was any similar synergistic effect between AZA and inhibitors of H3K9 methylation, we treated FXS cells with AZA to initially reactivate the FMR1 gene, followed by treatment with either DMSO or small molecule inhibitors of H3K9 methylation. This evidence concerns the gene FMR1 and fragile X syndrome.